Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

• Status: Completed
• Trial end date: 2009-11-01

Summary

The purpose of this study is to determine whether the study drug is safe and effective.

• Phase: Phase 3

Details

• Lead Sponsor: Bayer
• Treatments: Betadex; Contraceptive Agents; Drospirenone; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Ethinyl Estradiol; Polyestradiol phosphate